Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of furazolidone-, clarithromycin-, and levofloxacin-based regimens for Helicobacter pylori infection
IRCT2016040318124N4Phase 3Completed
- Sponsor
- Investigator
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of furazolidone, clarithromycin and levofloxacin in Helicobacter pylori infection (3 arms), sponsored by Investigator. Started Jul 2017; status: completed.
02
Drugs
furazolidoneclarithromycinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT2016040318124N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016040318124N4.